A Multinational, Retrospective, Real-World Study: Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Beyond First-line in East Asia (HER2+ GASTA Study).
Saved in:
| Title: | A Multinational, Retrospective, Real-World Study: Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Beyond First-line in East Asia (HER2+ GASTA Study). |
|---|---|
| Authors: | Oh DY; Division of Medical Oncology, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Korea. ohdoyoun@snu.ac.kr., Yeo W; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong., Chen JS; Department of Hematology-Oncology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan., Ba Y; Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; Cancer Medical Center & Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China., Chan WWL; Department of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong., Chen MJ; Department of Gastroenterology, MacKay Memorial Hospital, Taipei, Taiwan., Chen YH; Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan., Gu K; Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Hung YP; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Kim JG; Division of Hemato-oncology, Kyungpook National University Chilgok Hospital, Daegu, Korea., Lee J; Department of Hematology and Oncology, Samsung Medical Center, Seoul, Korea., Liang X; Medical Oncology, Hubei Cancer Hospital, Wuhan, China., Luo S; Department of Medical Oncology, Henan Cancer Hospital, Zhengzhou, China., Rha SY; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Yuan Y; Department of Medical Oncology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China., Kim T; STAT Team, Linical Korea, Seoul, Korea., Yanagida M; Medical Affairs Group, ASCA Oncology Product Department, ASCA Business Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Sato R; Medical Affairs Group, ASCA Oncology Product Department, ASCA Business Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Xu RH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. |
| Source: | Cancer research and treatment [Cancer Res Treat] 2026 Jun 22. Date of Electronic Publication: 2026 Jun 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42341842 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Multinational, Retrospective, Real-World Study: Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Beyond First-line in East Asia (HER2+ GASTA Study). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Oh+DY%22">Oh DY</searchLink>; Division of Medical Oncology, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Korea. ohdoyoun@snu.ac.kr.<br /><searchLink fieldCode="AU" term="%22Yeo+W%22">Yeo W</searchLink>; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong.<br /><searchLink fieldCode="AU" term="%22Chen+JS%22">Chen JS</searchLink>; Department of Hematology-Oncology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Ba+Y%22">Ba Y</searchLink>; Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; Cancer Medical Center & Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Chan+WWL%22">Chan WWL</searchLink>; Department of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.<br /><searchLink fieldCode="AU" term="%22Chen+MJ%22">Chen MJ</searchLink>; Department of Gastroenterology, MacKay Memorial Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+YH%22">Chen YH</searchLink>; Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Gu+K%22">Gu K</searchLink>; Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.<br /><searchLink fieldCode="AU" term="%22Hung+YP%22">Hung YP</searchLink>; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Kim+JG%22">Kim JG</searchLink>; Division of Hemato-oncology, Kyungpook National University Chilgok Hospital, Daegu, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; Department of Hematology and Oncology, Samsung Medical Center, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Liang+X%22">Liang X</searchLink>; Medical Oncology, Hubei Cancer Hospital, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Luo+S%22">Luo S</searchLink>; Department of Medical Oncology, Henan Cancer Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Rha+SY%22">Rha SY</searchLink>; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Yuan+Y%22">Yuan Y</searchLink>; Department of Medical Oncology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Kim+T%22">Kim T</searchLink>; STAT Team, Linical Korea, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Yanagida+M%22">Yanagida M</searchLink>; Medical Affairs Group, ASCA Oncology Product Department, ASCA Business Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+R%22">Sato R</searchLink>; Medical Affairs Group, ASCA Oncology Product Department, ASCA Business Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Xu+RH%22">Xu RH</searchLink>; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101155137%22">Cancer research and treatment</searchLink> [Cancer Res Treat] 2026 Jun 22. <i>Date of Electronic Publication: </i>2026 Jun 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Korean+Cancer+Association%22">Korean Cancer Association </searchLink><i>Country of Publication: </i>Korea (South) <i>NLM ID: </i>101155137 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2005-9256 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215982998%22">15982998 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res Treat <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42341842 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.4143/crt.2025.1341 Languages: – Code: eng Text: English Titles: – TitleFull: A Multinational, Retrospective, Real-World Study: Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Beyond First-line in East Asia (HER2+ GASTA Study). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Oh DY – PersonEntity: Name: NameFull: Yeo W – PersonEntity: Name: NameFull: Chen JS – PersonEntity: Name: NameFull: Ba Y – PersonEntity: Name: NameFull: Chan WWL – PersonEntity: Name: NameFull: Chen MJ – PersonEntity: Name: NameFull: Chen YH – PersonEntity: Name: NameFull: Gu K – PersonEntity: Name: NameFull: Hung YP – PersonEntity: Name: NameFull: Kim JG – PersonEntity: Name: NameFull: Lee J – PersonEntity: Name: NameFull: Liang X – PersonEntity: Name: NameFull: Luo S – PersonEntity: Name: NameFull: Rha SY – PersonEntity: Name: NameFull: Yuan Y – PersonEntity: Name: NameFull: Kim T – PersonEntity: Name: NameFull: Yanagida M – PersonEntity: Name: NameFull: Sato R – PersonEntity: Name: NameFull: Xu RH IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 06 Text: 2026 Jun 22 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2005-9256 Titles: – TitleFull: Cancer research and treatment Type: main |
| ResultId | 1 |
